H.C. Wainwright raises target for Calumet stock to USD 75.00

Published on 10/05/2026 at 05:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Calumet raised ABL commitments by USD 100.00 million on September 14, 2026. Analysts set a USD 53.40 consensus target for Calumet stock.

CLMT, US1314281049, Illustration mit AI erstellt.

H.C. Wainwright raised its target for Calumet stock from USD 60.00 to USD 75.00 on September 2, 2026, according to MarketBeat. The target change sits alongside a financing update that gives Calumet more working-capital capacity.

Liquidity rises by USD 100 million

On September 14, 2026, Calumet increased commitments under its asset-based loan facility from USD 500.00 million to USD 600.00 million and received a final USD 34.00 million draw under a U.S. Department of Energy loan guarantee, PR Newswire reported. The facility maturity remains in January 2031, while the remaining capital planned for the MaxSAF expansion is USD 137.00 million, down from the original USD 1.20 billion Phase 2 concept.

The financing matters because Calumet is funding specialty products and renewable fuels while commodity prices fluctuate. The larger borrowing base reflects higher prices and receivables, but the facility remains subject to borrowing-base limits.

Revenue grows while losses remain

For the quarter ended June 30, 2026, Calumet generated USD 1.45 billion in revenue, up 40.80 percent from USD 1.03 billion a year earlier, while its GAAP net loss narrowed to USD 95.90 million from USD 147.90 million, according to Markets Insider. The quarter still included a USD 1.09 adjusted loss per share, compared with a consensus expectation of USD 0.07 earnings per share.

That split is the central operating tension: sales expanded sharply, but earnings remained negative. H.C. Wainwright's USD 75.00 target is therefore a forward-looking analyst view rather than a reflection of positive GAAP earnings in the latest quarter.

Target stays above the market quote

Markets Insider listed a consensus target of USD 53.40, while the H.C. Wainwright target was USD 75.00 on September 22, 2026. The difference shows a wide range of analyst views, with the higher target requiring improved profitability from Calumet's specialty products and renewable fuels operations.

On October 2, 2026, Calumet last stood at USD 55.28 on Nasdaq at 4:00 p.m. ET. The quote was USD 4.59, or 7.67 percent, below the USD 59.87 52-week high, while market capitalization stood at USD 4.8 billion.